Cargando…
Research progress of circRNA in malignant tumour metabolic reprogramming
Cancer is a multi-factor systemic malignant disease, which has seriously threatened human health and created a heavy burden on the world economy. Metabolic reprogramming, one of the important signs of malignant tumours, provides necessary nutrition for tumorigenesis and cancer development; thus, it...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443989/ https://www.ncbi.nlm.nih.gov/pubmed/37599427 http://dx.doi.org/10.1080/15476286.2023.2247877 |
_version_ | 1785093955516366848 |
---|---|
author | Geng, Yikun Wang, Min Wu, Zhouying Jia, Jianchao Yang, Tingyu Yu, Lan |
author_facet | Geng, Yikun Wang, Min Wu, Zhouying Jia, Jianchao Yang, Tingyu Yu, Lan |
author_sort | Geng, Yikun |
collection | PubMed |
description | Cancer is a multi-factor systemic malignant disease, which has seriously threatened human health and created a heavy burden on the world economy. Metabolic reprogramming, one of the important signs of malignant tumours, provides necessary nutrition for tumorigenesis and cancer development; thus, it has recently become a research hot spot, even though the metabolic mechanism is quite intricate. Circular RNA (circRNA) affects cancer cell metabolism through various molecular mechanisms, playing an important role in promoting or suppressing cancer. Because of the structure characteristics, circRNA is quite stable, and can be utilized as biomarkers. In this review, we analysed and summarized the characteristics and biological functions of circRNA and comprehensively reviewed and discussed the important role of circRNA in cancer metabolic reprogramming. This review will provide new ideas for developing new anti-cancer therapeutic targets, mining cancer diagnostic and prognostic markers, and will provide guidance for other researchers to design circRNA-related experiments and develop anti-tumour drugs. |
format | Online Article Text |
id | pubmed-10443989 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-104439892023-08-23 Research progress of circRNA in malignant tumour metabolic reprogramming Geng, Yikun Wang, Min Wu, Zhouying Jia, Jianchao Yang, Tingyu Yu, Lan RNA Biol Review Cancer is a multi-factor systemic malignant disease, which has seriously threatened human health and created a heavy burden on the world economy. Metabolic reprogramming, one of the important signs of malignant tumours, provides necessary nutrition for tumorigenesis and cancer development; thus, it has recently become a research hot spot, even though the metabolic mechanism is quite intricate. Circular RNA (circRNA) affects cancer cell metabolism through various molecular mechanisms, playing an important role in promoting or suppressing cancer. Because of the structure characteristics, circRNA is quite stable, and can be utilized as biomarkers. In this review, we analysed and summarized the characteristics and biological functions of circRNA and comprehensively reviewed and discussed the important role of circRNA in cancer metabolic reprogramming. This review will provide new ideas for developing new anti-cancer therapeutic targets, mining cancer diagnostic and prognostic markers, and will provide guidance for other researchers to design circRNA-related experiments and develop anti-tumour drugs. Taylor & Francis 2023-08-20 /pmc/articles/PMC10443989/ /pubmed/37599427 http://dx.doi.org/10.1080/15476286.2023.2247877 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. |
spellingShingle | Review Geng, Yikun Wang, Min Wu, Zhouying Jia, Jianchao Yang, Tingyu Yu, Lan Research progress of circRNA in malignant tumour metabolic reprogramming |
title | Research progress of circRNA in malignant tumour metabolic reprogramming |
title_full | Research progress of circRNA in malignant tumour metabolic reprogramming |
title_fullStr | Research progress of circRNA in malignant tumour metabolic reprogramming |
title_full_unstemmed | Research progress of circRNA in malignant tumour metabolic reprogramming |
title_short | Research progress of circRNA in malignant tumour metabolic reprogramming |
title_sort | research progress of circrna in malignant tumour metabolic reprogramming |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443989/ https://www.ncbi.nlm.nih.gov/pubmed/37599427 http://dx.doi.org/10.1080/15476286.2023.2247877 |
work_keys_str_mv | AT gengyikun researchprogressofcircrnainmalignanttumourmetabolicreprogramming AT wangmin researchprogressofcircrnainmalignanttumourmetabolicreprogramming AT wuzhouying researchprogressofcircrnainmalignanttumourmetabolicreprogramming AT jiajianchao researchprogressofcircrnainmalignanttumourmetabolicreprogramming AT yangtingyu researchprogressofcircrnainmalignanttumourmetabolicreprogramming AT yulan researchprogressofcircrnainmalignanttumourmetabolicreprogramming |